These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1127 related articles for article (PubMed ID: 2477829)

  • 1. Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody.
    Lam KW; Li CY; Yam LT; Sun T; Lee G; Ziesmer S
    Prostate; 1989; 15(1):13-21. PubMed ID: 2477829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
    Shah NT; Tuttle SE; Strobel SL; Gandhi L
    J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical detection of prostate carcinoma].
    Ma WX; Li W
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study of prostatic acid phosphatase and prostatic specific antigen in prostatic carcinoma--a comparison of monoclonal antibody to polyclonal antibody].
    Moriyama N; Taniguchi J; Hara M; Fukutani K; Matsushima H; Murakami T; Isurugi K; Kawabe K; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1992-7. PubMed ID: 2453695
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
    Steffens J; Friedmann W; Lobeck H
    Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining.
    Varma M; Berney DM; Jasani B; Rhodes A
    J Clin Pathol; 2004 Jul; 57(7):687-90. PubMed ID: 15220358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
    Fincker F; Sauvan R; Pasquier J
    Am J Clin Oncol; 1988; 11 Suppl 2():S68-70. PubMed ID: 2468277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of prostatic acid phosphatase.
    Yam LT; Janckila AJ; Lam WK; Li CY
    Prostate; 1981; 2(1):97-107. PubMed ID: 7024961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
    Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical determination of prostate-specific acid phosphatase (PSAP), prostate-specific antigen (PSA) and epithelial membrane antigen (EMA) with monoclonal antibodies in punch biopsies of the prostate].
    Wacker U; Müller HA
    Verh Dtsch Ges Pathol; 1986; 70():325-8. PubMed ID: 2435081
    [No Abstract]   [Full Text] [Related]  

  • 12. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
    Wells DJ; Bennett BD; Gardner WA
    South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
    Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
    Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
    Morote J; Ruibal A; Pascual C; Palou J; de Torres JA
    J Urol; 1987 May; 137(5):891-3. PubMed ID: 2437332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
    Mansi JL; Berger U; Wilson P; Shearer R; Coombes RC
    J Urol; 1988 Mar; 139(3):545-8. PubMed ID: 2449548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with prostate-specific antigen in prostatic carcinoma.
    Romics I; Bach D
    Int Urol Nephrol; 1991; 23(5):465-72. PubMed ID: 1718923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
    Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
    Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
    Rock RC; Chan DW; Bruzek D; Waldron C; Oesterling J; Walsh P
    Clin Chem; 1987 Dec; 33(12):2257-61. PubMed ID: 2446807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.